LALPATHLAB — Dr. Lal PathLabs Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual income statement for Dr. Lal PathLabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	20,874	20,169	22,266	24,614	27,629
Cost of Revenue
Gross Profit	15,630	15,438	17,490	19,528	22,000
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	16,329	16,772	17,585	19,021	21,673
Operating Profit	4,545	3,396	4,681	5,593	5,957
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4,750	3,438	5,055	6,248	6,691
Provision for Income Taxes
Net Income After Taxes	3,503	2,411	3,623	4,923	5,098
Minority Interest
Net Income Before Extraordinary Items
Net Income	3,448	2,388	3,577	4,871	5,048
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	3,448	2,388	3,577	4,871	5,048
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	20.8	14.3	21.5	29.3	31.6
Dividends per Share